Skip to content
Screener

Treasury Stock at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$10M+25.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$533.28M+65.0%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$10.98M0.0%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.38B+420%
Enterprise value$12.3B+421%
P/S19.9×+15.7×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Additional paid-in capital2,395,2672,139,725
Accumulated other comprehensive income7426,443
Accumulated deficit(1,729,075)(1,627,154)
Treasury stock; at cost; 2,661 shares of common stock at March 31, 2026 and September 30, 2025(53,193)(53,193)
Stockholders’ equity613,977466,052
Noncontrolling interest(15,061)37,364
Total noncontrolling interest and stockholders’ equity598,916503,416
Total Liabilities, Noncontrolling Interest and Stockholders’ Equity$2,268,265$1,385,295

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's treasury stock?
Arrowhead Research (ARWR) reported treasury stock of $53.19M in Q1 2026.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

Ask your AI about Arrowhead Research's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude